Antibodies to elastin peptides in sera of Belgian Draught horses with chronic progressive lymphoedema.

The research investigates the connection between elevated serum anti-elastin antibody levels and the disease Chronic Progressive Lymphoedema (CPL) in draught horses. It finds that higher levels are linked to severity of the ailment and suggests the use of these antibodies as a diagnostic tool.

Research Background and Objective

• The study focuses on Chronic Progressive Lymphoedema (CPL), a disease affecting the lower legs in several draught horse breeds.
• CPL tends to manifest as skin lesions that gradually worsen, often leading to severe limb disfigurement.
• Though supportive treatment ideally commences early in the disease’s progression, diagnosing and monitoring CPL remains a difficult task.
• The researchers believe that elastin changes occurring in the skin of horses with CPL might be connected with an increased release of elastin degradation products.
• This process, in turn, may lead to the production of anti-elastin antibodies (AEAbs) in the serum.
• The objective of the research is to determine if an enzyme-linked immunosorbent assay (ELISA) could detect these antibodies and provide an indication of elastin breakdown.

Research Methodology

• A group of 97 Belgian Draught horses, some of which were clinically healthy (except for potential skin lesions associated with CPL) were examined using an ELISA method.
• The horses were divided into five groups based on the severity of their skin lesions.
• The groups ranged from normal horses (Group 1) to those with mild lesions (Group 2), moderate lesions (Group 3), and severe lesions (Group 4).
• A control group of healthy Warmblood horses, unaffected by CPL, was also included (Group 5).

Research Findings and Conclusion

• The study found that horses exhibiting clinical signs of CPL had significantly higher AEAb levels when compared to normal Belgian Draught horses and to the healthy Warmblood horses.
• Furthermore, the levels of antibodies were found to correlate with the severity of the lesions.
• The results suggest CPL in draught horses is associated with an increase of serum AEAbs.
• Evaluating serum AEAbs levels using ELISA could be a practical tool for diagnosing CPL.
• The research concluded by proposing that pathological degradation of elastic fibres leading to deficient support of distal lymphatics might be a contributing factor to CPL in Belgian Draught horses.